Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 3,763 | 6,236 | 6,835 | 8,245 | 0 |
| Gross Profit | 3,763 | 6,236 | 6,835 | 8,245 | 0 |
| Operating Expenses | 6,051 | 6,504 | 9,367 | 11,119 | 470 |
| Operating Income | -2,288 | -268 | -2,532 | -2,874 | -470 |
| Interest Expense | 0 | 0 | 0 | 0 | 50 |
| Other Income | 613 | 233 | 387 | 868 | -230 |
| Pre-tax Income | -1,675 | -35 | -2,145 | -2,006 | -750 |
| Income Tax | -363 | -1 | -321 | N/A | 0 |
| Net Income Continuous | -1,312 | -34 | -1,824 | -1,389 | -750 |
| Net Income | $-1,312 | $-34 | $-1,824 | $-1,389 | $-750 |
| EPS Basic Total Ops | -0.21 | 0.00 | -0.28 | -0.35 | N/A |
| EPS Basic Continuous Ops | -0.22 | -0.01 | -0.30 | -0.26 | N/A |
| EPS Diluted Total Ops | -0.21 | 0.00 | -0.28 | -0.28 | N/A |
| EPS Diluted Continuous Ops | -0.22 | -0.01 | -0.30 | -0.25 | N/A |
| EBITDA(a) | $-2,225 | $-201 | $-2,466 | $-2,773 | $-470 |